| Computational methods in developing quantitative structure-activity relationships (QSAR): a review AZ Dudek, T Arodz, J Gálvez Combinatorial chemistry & high throughput screening 9 (3), 213-228, 2006 | 519 | 2006 |
| Charge indexes. New topological descriptors J Galvez, R Garcia, MT Salabert, R Soler Journal of Chemical Information and Computer Sciences 34 (3), 520-525, 1994 | 410 | 1994 |
| Some new trends in chemical graph theory R García-Domenech, J Gálvez, JV de Julián-Ortiz, L Pogliani Chemical Reviews 108 (3), 1127-1169, 2008 | 345 | 2008 |
| Topological approach to drug design J Galvez, R Garcia-Domenech, JV de Julian-Ortiz, R Soler Journal of chemical information and computer sciences 35 (2), 272-284, 1995 | 255 | 1995 |
| Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds JV de Julián-Ortiz, J Gálvez, C Muñoz-Collado, R García-Domenech, ... Journal of Medicinal Chemistry 42 (17), 3308-3314, 1999 | 163 | 1999 |
| Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening N Mahmoudi, JV de Julian-Ortiz, L Ciceron, J Galvez, D Mazier, M Danis, ... Journal of Antimicrobial Chemotherapy 57 (3), 489-497, 2006 | 139 | 2006 |
| Pharmacological distribution diagrams: a tool for de novo drug design J Gálvez, R García-Domenech, C de Gregorio Alapont, JV de Julián-Ortiz, ... Journal of Molecular Graphics 14 (5), 272-276, 1996 | 133 | 1996 |
| Prediction of properties of chiral compounds by molecular topology JV de Julián-Ortiz, C de Gregorio Alapont, I Rıos-Santamarina, ... Journal of Molecular Graphics and Modelling 16 (1), 14-18, 1998 | 118 | 1998 |
| Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity L Bruno-Blanch, J Galvez, R Garcıa-Domenech Bioorganic & medicinal chemistry letters 13 (16), 2749-2754, 2003 | 108 | 2003 |
| New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method Á García-García, J Gálvez, JV de Julián-Ortiz, R García-Domenech, ... Journal of Antimicrobial Chemotherapy 53 (1), 65-73, 2004 | 98 | 2004 |
| New Active Drugs against Liver Stages of Plasmodium Predicted by Molecular Topology N Mahmoudi, R Garcia-Domenech, J Galvez, K Farhati, JF Franetich, ... Antimicrobial Agents and Chemotherapy 52 (4), 1215-1220, 2008 | 90 | 2008 |
| Anti-Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Techniques R Gozalbes, M Brun-Pascaud, R Garcia-Domenech, J Galvez, PM Girard, ... Antimicrobial Agents and Chemotherapy 44 (10), 2771-2776, 2000 | 80 | 2000 |
| Topological approach to analgesia J Galvez, R Garcia-Domenech, V De Julian-Ortiz, R Soler Journal of Chemical Information and Computer Sciences 34 (5), 1198-1203, 1994 | 77 | 1994 |
| Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir CL Bellera, DE Balcazar, MC Vanrell, AF Casassa, PH Palestro, ... European journal of medicinal chemistry 93, 338-348, 2015 | 73 | 2015 |
| In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii R Guna, C Munoz, V Domínguez, Á García-García, J Gálvez, ... Journal of Antimicrobial Chemotherapy 55 (6), 950-953, 2005 | 67 | 2005 |
| Molecular Search of New Active Drugs Against Toxoplasma Gondii R Gozalbes, J Galvez, R Garcia-Domenech, F Derouin SAR and QSAR in Environmental Research 10 (1), 47-60, 1999 | 65 | 1999 |
| New bronchodilators selected by molecular topology I Rios-Santamarina, R Garcia-Domenech, J Gálvez, J Cortijo, ... Bioorganic & medicinal chemistry letters 8 (5), 477-482, 1998 | 64 | 1998 |
| Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1, 2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug MC Vega, M Rolón, A Montero-Torres, C Fonseca-Berzal, JA Escario, ... European journal of medicinal chemistry 58, 214-227, 2012 | 62 | 2012 |
| A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma … P Jasinski, B Welsh, J Galvez, D Land, P Zwolak, L Ghandi, K Terai, ... Investigational new drugs 26, 223-232, 2008 | 59 | 2008 |
| Search of chemical scaffolds for novel antituberculosis agents A García-García, J Gálvez, JV de Julián-Ortiz, R García-Domenech, ... SLAS Discovery 10 (3), 206-214, 2005 | 59 | 2005 |
